The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Podcasts
Allen Archer, System Director of Supply Chain at Houston Healthcare, leads a thought-leader panel discussion about the role of GPOs within the chan
Podcasts
Nexera has incorporated Cost, Quality, and Outcomes (CQO) throughout their own organizational culture, and embeds that philosophy into their partne
Podcasts
Lana Makhanik and Peter Fiorentino discuss discus why Beth Israel Deaconess Medical Center is breathing easier after they overhauled their inventor
Podcasts
Professional Coach Mark Noon discusses the types of skills and actions that a leader needs to create a team-oriented culture.
Podcasts
Donna Gammarato discusses the importance of creating specialized Value Analysis teams to analyze resource utilization and reduce costs.
On-Demand Educational Webinars
When purchasing is involved at the start of the capital equipment process, it can lead to better value outcomes and improved customer experience at…